Article Text

Download PDFPDF
CASE REPORT
Mild androgen insensitivity syndrome (MAIS): the identification of c.1783C>T mutation in two unrelated infertile men
  1. Ghalia Abou Alchamat1,
  2. Ammar Madania2,
  3. Marwan Alhalabi3,4
  1. 1Department of Biology, Faculty of Sciences, Damascus University, Damascus, Syrian Arab Republic
  2. 2Department of Radiation Medicine, Atomic Energy Commission, Damascus, Syrian Arab Republic
  3. 3Department of Reproductive Medicine, Genetics and Embryology, Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic
  4. 4Assisted Reproduction Unit, Orient Hospital, Damascus, Syrian Arab Republic
  1. Correspondence to Professor Marwan Alhalabi, profalhalabi{at}icloud.com

Summary

Two unrelated men complaining of primary male infertility presented to Orient Hospital in Damascus city. Physical examination showed moderate hypoandrogenic features. Both men were azoospermic. Hormone profiles revealed an elevation of follicle-stimulating hormone in one patient, but all the other hormones tested were within normal limits for both patients. Further genetic analyses, including karyotype and microdeletions in the AZF region of the Y chromosome, were normal in both patients. Mild androgen insensitivity syndrome was expected in the two patients. Sequencing analysis of the first exon in the androgen receptor (AR) gene have shown c.1783C>T mutation in the two patients with azoospermia. This paper sheds light on the need to screen for mutations in the AR gene, causing male infertility whenever mild hypoandrogenic features are present with unexplained male infertility.

  • genetics
  • reproductive medicine

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Twitter https://twitter.com/marwan_alhalabi

  • Contributors MA clinically approached the patient. AM performed genetic investigations. GAA performed the sequencing analysis. GAA and AM drafted the initial manuscript. MA revised and reviewed the manuscript. All authors have reviewed the final version of the manuscript and approved the submission process.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.